超分子化学
化学
体内
共轭体系
体外
组合化学
单克隆抗体
生物物理学
共价键
超分子组装
纳米技术
临床前影像学
抗体
显像剂
Pet成像
分子成像
超分子聚合物
生物结合
生物化学
生物相容性材料
作者
Romane Vizier,Milou Boswinkel,Mathieu Moreau,Johan Faivre,Manon Carrierre,Maxime Cheveau,Sophie Poty,Franck Denat,Sanne A. M. van Lith,Victor Gonçalves
标识
DOI:10.1021/acs.molpharmaceut.5c01339
摘要
Monoclonal antibodies have proven to be highly effective for in vivo targeting in nuclear medicine applications. However, typical radiolabeling methods, for PET/SPECT imaging and targeted radionuclide therapy, often require conditions that may affect the structural integrity of these fragile biomolecules. In this study, we introduce a novel methodology, based on supramolecular chemistry, for efficient radiolabeling of antibodies under mild conditions. Specifically, we report the synthesis of DOTA-cucurbit[7]uril (DOTA-CB[7]), a precursor that can be readily radiolabeled with a variety of radionuclides ( 111 In, 68 Ga, 89 Zr, 177 Lu, 225 Ac). [ 111 In]In-DOTA-CB[7] was conjugated to an anti-HER2 antibody (trastuzumab) site─specifically grafted with adamantan-1-amine groups. The supramolecular conjugation, driven by the exceptionally strong affinity between CB[7] and adamantan-1-amine enabled rapid and efficient formation of a stable antibody–radiometal complex under mild conditions. The resulting radioimmunoconjugate demonstrated high in vitro and in vivo stability and effective targeting of HER2+ tumors, as evidenced by SPECT/CT imaging in mice xenografted with HER2+ SKOV-3 cells. These findings highlight the potential of DOTA-CB[7] for supramolecular radiolabeling, offering a simple and versatile alternative to traditional covalent approaches, particularly for applications requiring compatibility with heat-sensitive biomolecules.
科研通智能强力驱动
Strongly Powered by AbleSci AI